Item 2 of 42 (back to results) previous next   3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one C006261               MeSH Unique Identifier: C006261 Scope Notes: Inhibits cycloartenol synthase Click here for more information

Current search: D27. Chemical Actions and Uses: Pharmacologic Actions [MESH:D020228] > Therapeutic Uses [MESH:D045506] > Lipid Regulating Agents [MESH:D057847] × Select any link to see items in a related category. more general categories    information about this item C01. Bacterial Infections and Mycoses  C01. Bacterial Infections and Mycoses  Bacterial Infections [MESH:D001424] (3716)   Gram-Negative Bacterial Infections [MESH:D016905] (3085)   Pasteurellaceae Infections [MESH:D016871] (348) C04. Neoplasms  C04. Neoplasms  Neoplasms [MESH:D009369] (10293)   Neoplasms by Histologic Type [MESH:D009370] (8793)   Neoplasms, Glandular and Epithelial [MESH:D009375] (7760)   Carcinoma [MESH:D002277] (7263)   Adenocarcinoma [MESH:D000230] (6565)   Carcinoma, Hepatocellular [MESH:D006528] (5375)  Neoplasms by Site [MESH:D009371] (9169)   Digestive System Neoplasms [MESH:D004067] (7487)   Liver Neoplasms [MESH:D008113] (6048)   Carcinoma, Hepatocellular [MESH:D006528] (5375) C05. Musculoskeletal Diseases  C05. Musculoskeletal Diseases  Musculoskeletal Diseases [MESH:D009140] (8705)   Joint Diseases [MESH:D007592] (4657)   Arthritis [MESH:D001168] (4416)   Arthritis, Experimental [MESH:D001169] (3142) C06. Digestive System Diseases  C06. Digestive System Diseases  Digestive System Diseases [MESH:D004066] (9461)   Digestive System Neoplasms [MESH:D004067] (7493)   Liver Neoplasms [MESH:D008113] (6048)   Carcinoma, Hepatocellular [MESH:D006528] (5375)  Liver Diseases [MESH:D008107] (8167)   Hepatolenticular Degeneration [MESH:D006527] (473)  Liver Neoplasms [MESH:D008113] (6048)   Carcinoma, Hepatocellular [MESH:D006528] (5375) C10. Nervous System Diseases  C10. Nervous System Diseases  Nervous System Diseases [MESH:D009422] (13325)   Central Nervous System Diseases [MESH:D002493] (9745)   Brain Diseases [MESH:D001927] (9294)   Dementia [MESH:D003704] (4498)  Basal Ganglia Diseases [MESH:D001480] (4268)   Hepatolenticular Degeneration [MESH:D006527] (473)  Parkinsonian Disorders [MESH:D020734] (4009)   Parkinson Disease [MESH:D010300] (3595)  Brain Diseases, Metabolic [MESH:D001928] (3351)   Brain Diseases, Metabolic, Inborn [MESH:D020739] (2634)   Hepatolenticular Degeneration [MESH:D006527] (473)  Movement Disorders [MESH:D009069] (4823)   Dyskinesias [MESH:D020820] (1827)  Hepatolenticular Degeneration [MESH:D006527] (473)  Parkinsonian Disorders [MESH:D020734] (4009)   Parkinson Disease [MESH:D010300] (3595)  Neurodegenerative Diseases [MESH:D019636] (6613)   Familial apoceruloplasmin deficiency [MESH:C536004] (211)  Parkinson Disease [MESH:D010300] (3595)  Heredodegenerative Disorders, Nervous System [MESH:D020271] (3243)   Hepatolenticular Degeneration [MESH:D006527] (473)  Neurologic Manifestations [MESH:D009461] (8964)   Dyskinesias [MESH:D020820] (3365)   Ataxia [MESH:D001259] (1138) C11. Eye Diseases  C11. Eye Diseases  Eye Diseases [MESH:D005128] (6245)   Retinal Diseases [MESH:D012164] (3747)   Retinal Degeneration [MESH:D012162] (2386) C12. Male Urogenital Diseases  C12. Male Urogenital Diseases  Male Urogenital Diseases [MESH:D052801] (8891)   Urologic Diseases [MESH:D014570] (7792)   Urination Disorders [MESH:D014555] (3598)   Proteinuria [MESH:D011507] (3293)   Albuminuria [MESH:D000419] (2394) C13. Female Urogenital Diseases and Pregnancy Complications  C13. Female Urogenital Diseases and Pregnancy Complications  Female Urogenital Diseases [MESH:D052776] (8724)   Urologic Diseases [MESH:D014570] (7793)   Urination Disorders [MESH:D014555] (3598)   Proteinuria [MESH:D011507] (3293)   Albuminuria [MESH:D000419] (2394)  Pregnancy Complications [MESH:D011248] (4768)   Hypertension, Pregnancy-Induced [MESH:D046110] (1453)   Pre-Eclampsia [MESH:D011225] (1435) C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities  C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities  Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] (12152)   Genetic Diseases, Inborn [MESH:D030342] (9766)   Heredodegenerative Disorders, Nervous System [MESH:D020271] (3465)   Hepatolenticular Degeneration [MESH:D006527] (473)  Metabolism, Inborn Errors [MESH:D008661] (6032)   Brain Diseases, Metabolic, Inborn [MESH:D020739] (2634)   Hepatolenticular Degeneration [MESH:D006527] (473)  Metal Metabolism, Inborn Errors [MESH:D008664] (2017)   Hemochromatosis [MESH:D006432] (1694)  Hepatolenticular Degeneration [MESH:D006527] (473) C17. Skin and Connective Tissue Diseases  C17. Skin and Connective Tissue Diseases  Skin Diseases [MESH:D012871] (8774)   Skin Diseases, Papulosquamous [MESH:D017444] (3392)   Psoriasis [MESH:D011565] (3278) C18. Nutritional and Metabolic Diseases  C18. Nutritional and Metabolic Diseases  Metabolic Diseases [MESH:D008659] (9025)   Brain Diseases, Metabolic [MESH:D001928] (3350)   Brain Diseases, Metabolic, Inborn [MESH:D020739] (2634)   Hepatolenticular Degeneration [MESH:D006527] (473)  Glucose Metabolism Disorders [MESH:D044882] (6122)   Diabetes Mellitus [MESH:D003920] (5891)   Diabetes Mellitus, Type 1 [MESH:D003922] (1897)  Iron Metabolism Disorders [MESH:D019189] (2139)   Familial apoceruloplasmin deficiency [MESH:C536004] (211)  Iron Overload [MESH:D019190] (1772)   Hemochromatosis [MESH:D006432] (1694)  Metabolism, Inborn Errors [MESH:D008661] (6028)   Brain Diseases, Metabolic, Inborn [MESH:D020739] (2634)   Hepatolenticular Degeneration [MESH:D006527] (473)  Metal Metabolism, Inborn Errors [MESH:D008664] (2017)   Hemochromatosis [MESH:D006432] (1694)  Hepatolenticular Degeneration [MESH:D006527] (473)  Nutrition Disorders [MESH:D009748] (4945)   Malnutrition [MESH:D044342] (2754)   Deficiency Diseases [MESH:D003677] (2742) C19. Endocrine System Diseases  C19. Endocrine System Diseases  Endocrine System Diseases [MESH:D004700] (8062)   Diabetes Mellitus [MESH:D003920] (6159)   Diabetes Mellitus, Type 1 [MESH:D003922] (1897) C20. Immune System Diseases  C20. Immune System Diseases  Immune System Diseases [MESH:D007154] (7674)   Autoimmune Diseases [MESH:D001327] (5067)   Diabetes Mellitus, Type 1 [MESH:D003922] (1893) C23. Pathological Conditions, Signs and Symptoms  C23. Pathological Conditions, Signs and Symptoms  Pathologic Processes [MESH:D010335] (9863)   Ischemia [MESH:D007511] (3049)  Nerve Degeneration [MESH:D009410] (4061)  Signs and Symptoms [MESH:D012816] (10659)   Neurologic Manifestations [MESH:D009461] (8702)   Dyskinesias [MESH:D020820] (3285)   Ataxia [MESH:D001259] (984)  Urological Manifestations [MESH:D020924] (3532)   Proteinuria [MESH:D011507] (3293)   Albuminuria [MESH:D000419] (2394) D04. Polycyclic Compounds  D04. Polycyclic Compounds  Polycyclic Compounds [MESH:D011083] (22048)   Steroids [MESH:D013256] (6272)   Androstanes [MESH:D000731] (757)   Androstenes [MESH:D000736] (507) D27. Chemical Actions and Uses  D27. Chemical Actions and Uses  Pharmacologic Actions [MESH:D020228] (2566)   Molecular Mechanisms of Pharmacological Action [MESH:D045504] (1155)   Enzyme Inhibitors [MESH:D004791] (520)  Antimetabolites [MESH:D000963] (33)   Hypolipidemic Agents [MESH:D000960] (25)   Anticholesteremic Agents [MESH:D000924] (23)  Therapeutic Uses [MESH:D045506] (1611)   Lipid Regulating Agents [MESH:D057847] (42)   Hypolipidemic Agents [MESH:D000960] (41)   Anticholesteremic Agents [MESH:D000924] (23)